Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burrell

Showing results (151-160 of 381) with videos related to

Pageof 39
Sort By:
Experimental Physiology|May 5, 2000
Vasopressin receptor antagonism--a therapeutic option in heart failure and hypertensionL M Burrell, J Risvanis, C I Johnston, et al.
American Journal of Physiology. Renal Physiology|September 25, 2015
MicroRNAs mediate the cardioprotective effect of angiotensin-converting enzyme inhibition in acute kidney injuryIndrajeetsinh Rana, Elena Velkoska, Sheila K Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1991
Expression of an antisense viral gene in transgenic tobacco confers resistance to the DNA virus tomato golden mosaic virusA G Day, E R Bejarano, K W Buck, et al.
BMC Public Health|March 21, 2021
Excess mortality at Christmas due to cardiovascular disease in the HUNT study prospective population-based cohort in NorwayTrine Moholdt, Clifford Afoakwah, Paul Scuffham, et al.
Journal of Hypertension|June 8, 2001
In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilatR A Hubner, E Kubota, D J Casley, et al.
Cardiovascular Research|April 26, 2006
Vascular neutral endopeptidase inhibition improves endothelial function and reduces intimal hyperplasiaMelissa N Barber, Meetali Kanagasundaram, Colin R Anderson, et al.
Clinical Science (London, England : 1979)|July 1, 1997
Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495L M Burrell, N Farina, J Risvanis, et al.
Blood Pressure|March 1, 1994
Vasopressin and a nonpeptide antidiuretic hormone receptor antagonist (OPC-31260)L M Burrell, P A Phillips, J M Stephenson, et al.
Bone Marrow Transplantation|May 29, 1998
High-dose cyclophosphamide, etoposide and carboplatin with autologous bone marrow support for metastatic breast cancer: long-term resultsW J Baker, S J Vukelja, L M Burrell, et al.
Gastroenterology|May 1, 1976
Adenocarcinoma in biliary papillomatosisR D Neumann, V A LiVolsi, N S Rosenthal, et al.
Pageof 39

Showing results (151-160 of 381) with videos related to

Sort By:
Pageof 39
Experimental Physiology|May 5, 2000
Vasopressin receptor antagonism--a therapeutic option in heart failure and hypertensionL M Burrell, J Risvanis, C I Johnston, et al.
American Journal of Physiology. Renal Physiology|September 25, 2015
MicroRNAs mediate the cardioprotective effect of angiotensin-converting enzyme inhibition in acute kidney injuryIndrajeetsinh Rana, Elena Velkoska, Sheila K Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1991
Expression of an antisense viral gene in transgenic tobacco confers resistance to the DNA virus tomato golden mosaic virusA G Day, E R Bejarano, K W Buck, et al.
BMC Public Health|March 21, 2021
Excess mortality at Christmas due to cardiovascular disease in the HUNT study prospective population-based cohort in NorwayTrine Moholdt, Clifford Afoakwah, Paul Scuffham, et al.
Journal of Hypertension|June 8, 2001
In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilatR A Hubner, E Kubota, D J Casley, et al.
Cardiovascular Research|April 26, 2006
Vascular neutral endopeptidase inhibition improves endothelial function and reduces intimal hyperplasiaMelissa N Barber, Meetali Kanagasundaram, Colin R Anderson, et al.
Clinical Science (London, England : 1979)|July 1, 1997
Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495L M Burrell, N Farina, J Risvanis, et al.
Blood Pressure|March 1, 1994
Vasopressin and a nonpeptide antidiuretic hormone receptor antagonist (OPC-31260)L M Burrell, P A Phillips, J M Stephenson, et al.
Bone Marrow Transplantation|May 29, 1998
High-dose cyclophosphamide, etoposide and carboplatin with autologous bone marrow support for metastatic breast cancer: long-term resultsW J Baker, S J Vukelja, L M Burrell, et al.
Gastroenterology|May 1, 1976
Adenocarcinoma in biliary papillomatosisR D Neumann, V A LiVolsi, N S Rosenthal, et al.
Pageof 39